Persistence of symptoms in dengue patients: a clinical cohort study

Abstract

Background Dengue is commonly considered an acute illness and follows three phases: febrile, critical in some cases and recovery. However, a number of studies have described a continuation of dengue symptoms for weeks or months, extending the recovery phase. Here we evaluate this persistence of dengue symptoms during convalescence. Methods Our clinical cohort study included patients who sought medical services 48 to 144 h from the onset of fever at seven hospitals or ambulatory centers in Morelos, Mexico. Seventy-nine laboratory-confirmed dengue patients were followed up regularly using clinic and/or home visits and telephone calls for as long as symptoms persisted or up to 6 mo. Results In total, 55.7% of patients had dengue-related symptoms 1 mo after the onset of fever; pain and dermatological manifestations were the most common persistent symptoms. Prognostic factors for symptom persistence were: ≥4 d of fever (RR 1.72; 95% CI 1.35 to 2.19), platelet count ≤100 000/mm3 (RR 1.20; 95% CI 1.20 to 2.20), petechiae/bruises (RR 1.97; 95% CI 1.56 to 2.48) and abdominal pain/hepatomegaly (RR 1.79; 95% CI 1.41 to 2.28). Conclusions Persistence of dengue symptoms were common in laboratory-confirmed dengue patients. Manifestations related to tissue damage were associated with persistence after 30 d; host characteristics, such as age and health status before infection, were associated with prolonged persistence (>60 d). The burden of dengue may be higher than previously estimated.

The dengue virus NS1 protein conveys pro-inflammatory signals by docking onto human high-density lipoproteins

“…Further studies are now needed to investigate whether the formation of NS1-ApoE-positive lipoprotein complexes are part of a recovery mechanism from the host or whether NS1 continues its intoxication program during the convalescent phase. A number of studies have described a persistence of asthenia for weeks, extending well beyond the end of the acute clinical phase (78)(79)(80)(81).…”

Dengue fever in a multiple sclerosis patient taking Ocrelizumab

“…During the convalescence, she reported the persistence of late dengue symptoms with hair loss and peeling of skin. 5…”

Severe hemorrhage in a patient with dengue hemorrhagic fever after insertion of orthodontic mini-implants. A case report

“…Clinical symptoms start suddenly and widely, varying from oligosymptomatic (silent infection) and symptomatic (dengue fever) forms to severe states with hemorrhages (dengue hemorrhagic fever -DHF) and shock (dengue shock syndrome -DSS). [3,4].…”